<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Huang W</submitter><funding>NCI NIH HHS</funding><pagination>4527-35</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3482867</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31(42)</volume><pubmed_abstract>Although increasing evidence suggests a critical role for platelet-derived growth factor (PDGF) receptor β (β-PDGFR) signaling in prostate cancer (PCa) progression, the precise roles of β-PDGFR and PDGF isoform-specific cell signaling have not been delineated. Recently, we identified the PDGF-D isoform as a ligand for β-PDGFR in PCa and showed that PDGF-D is activated by serine protease-mediated proteolytic removal of the CUB domain in a two-step process, yielding first a hemidimer (HD) and then a growth factor domain dimer. Herein, we demonstrate that the expression of PDGF-D in human PCa LNCaP cells leads to enhanced bone tumor growth and bone responses in immunodeficient mice. Histopathological analyses of bone tumors generated by PDGF-D-expressing LNCaP cells (LNCaP-PDGF-D) revealed os</pubmed_abstract><journal>Oncogene</journal><pubmed_title>A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth.</pubmed_title><pmcid>PMC3482867</pmcid><funding_grant_id>CA123362</funding_grant_id><funding_grant_id>CA64139</funding_grant_id><funding_grant_id>R01 CA064139</funding_grant_id><funding_grant_id>R01 CA123362</funding_grant_id><funding_grant_id>T32-CA009531</funding_grant_id><funding_grant_id>R29 CA064139</funding_grant_id><funding_grant_id>R01 CA137280</funding_grant_id><funding_grant_id>T32 CA009531</funding_grant_id><funding_grant_id>R01CA137280</funding_grant_id><pubmed_authors>Fridman Y</pubmed_authors><pubmed_authors>Saliganan A</pubmed_authors><pubmed_authors>Cher ML</pubmed_authors><pubmed_authors>Wiesner C</pubmed_authors><pubmed_authors>Huang W</pubmed_authors><pubmed_authors>Bonfil RD</pubmed_authors><pubmed_authors>Ustach CV</pubmed_authors><pubmed_authors>Kim HR</pubmed_authors><pubmed_authors>Conley-LaComb MK</pubmed_authors></additional><is_claimable>false</is_claimable><name>A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth.</name><description>Although increasing evidence suggests a critical role for platelet-derived growth factor (PDGF) receptor β (β-PDGFR) signaling in prostate cancer (PCa) progression, the precise roles of β-PDGFR and PDGF isoform-specific cell signaling have not been delineated. Recently, we identified the PDGF-D isoform as a ligand for β-PDGFR in PCa and showed that PDGF-D is activated by serine protease-mediated proteolytic removal of the CUB domain in a two-step process, yielding first a hemidimer (HD) and then a growth factor domain dimer. Herein, we demonstrate that the expression of PDGF-D in human PCa LNCaP cells leads to enhanced bone tumor growth and bone responses in immunodeficient mice. Histopathological analyses of bone tumors generated by PDGF-D-expressing LNCaP cells (LNCaP-PDGF-D) revealed os</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Oct</publication><modification>2025-07-06T03:05:45.696Z</modification><creation>2025-07-06T03:05:45.696Z</creation></dates><accession>S-EPMC3482867</accession><cross_references><pubmed>22158043</pubmed><doi>10.1038/onc.2011.573</doi></cross_references></HashMap>